已核实 DOI PubMed 相关产品: 2

Injectable agents for the induction of Peyronie’s disease in model rats: a comparative study

Journal 2024 · IF 3 · 发表于 2024 年 8 月 13 日
作者: Du Guang-Jun,Xing Si-Yan,Wu Ning,Wang Tong,Jiang Yue-Hui,Song Tao,Yang Bai-Bing,Dai Yu-Tian
阅读全文 在 PubMed 查看

摘要

Peyronie’s disease (PD) is a disorder characterized by fibrous plaque formation in the penile tissue that leads to curvature and complications in advanced stages. In this study, we aimed to compare four injectable induction agents for the establishment of a robust rat model of PD: transforming growth factor-β1 (TGF-β1), fibrin, sodium tetradecyl sulfate (STS) combined with TGF-β1, and polidocanol (POL) combined with TGF-β1. The results showed that injection of TGF-β1 or fibrin into the tunica albuginea induced pathological endpoints without causing penile curvature. The STS + TGF-β1 combination resulted in both histological and morphological alterations, but with a high incidence of localized necrosis that led to animal death. The POL + TGF-β1 combination produced pathological changes and curvature comparable to STS + TGF-β1 and led to fewer complications. In conclusion, fibrin, STS + TGF-β1, and POL + TGF-β1 all induced PD with a certain degree of penile curvature and histological fibrosis in rats. The POL + TGF-β1 combination offered comparatively greater safety and clinical relevance and may have the greatest potential for PD research using model rats.

本研究中使用的阿拉丁产品

2 款产品在本文中被引用